Enterovirus D68 Uses Dual Receptors for Entry into Respiratory Cells
Researchers have identified a crucial mechanism by which enterovirus D68 (EV-D68) gains entry into human respiratory cells. This virus, known for causing severe respiratory illness, particularly in children, utilizes a two-step process involving two distinct cell receptors. Initially, EV-D68 binds to a primary receptor, sialic acid, on the surface of respiratory cells. This binding event is not sufficient for entry on its own but acts as a priming step. Following this initial interaction, the virus then engages a second receptor, integrin αVβ6. The simultaneous interaction with both sialic acid and integrin αVβ6 is essential for the virus to successfully penetrate the cell membrane and initiate infection. This dual-receptor checkpoint mechanism highlights a sophisticated strategy employed by EV-D68 to overcome cellular defenses. Understanding this process is vital for developing targeted antiviral therapies and preventative strategies against EV-D68 infections, which can lead to serious conditions like acute flaccid myelitis.
The discovery of EV-D68's dual-receptor entry mechanism offers a significant target for therapeutic intervention. By understanding the specific molecular interactions required for viral entry, researchers can explore strategies to block either the primary sialic acid binding or the subsequent integrin αVβ6 engagement. This could involve developing small molecule inhibitors or antibody-based therapies designed to prevent the virus from initiating infection. The long-term implications for public health involve mitigating the severity of EV-D68 outbreaks and potentially reducing the incidence of associated neurological complications. Future research may also investigate whether similar dual-receptor mechanisms are employed by other emerging respiratory viruses, suggesting a broader pattern in viral adaptation to host cells.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.